Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1

被引:359
作者
Diehl, S
Anguita, J
Hoffmeyer, A
Zapton, T
Ihle, JN
Fikrig, E
Rincón, M
机构
[1] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA
[3] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Biochem, Memphis, TN USA
关键词
D O I
10.1016/S1074-7613(00)00078-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 6 (IL-6) is a cytokine produced by immune and nonimmune cells and exhibits functional pleiotropy and redundancy. IL-6 plays an important role in the differentiation of several cell types. Here, we describe a novel function of IL-6: the negative regulation of CD4(+) Th1 cell differentiation. While IL-6-directed CD4(+) Th2 differentiation is mediated by IL-4, inhibition of Th1 differentiation by IL-6 is independent of IL-4. IL-6 upregulates suppressor of cytokine signaling 1 (SOCS1) expression in activated CD4(+) T cells, thereby interfering with signal transducer and activator of transcription 1 (STAT1) phosphorylation induced by interferon gamma (IFN gamma). Inhibition of IFN gamma receptor-mediated signals by IL-6 prevents autoregulation of IFN I gene expression by IFN gamma during CD4(+) T cell activation, thereby preventing Th1 differentiation. Thus, IL-6 promotes CD4(+) Th2 differentiation and inhibits Th1 differentiation by two independent molecular mechanisms.
引用
收藏
页码:805 / 815
页数:11
相关论文
共 59 条
  • [1] Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction
    Alexander, WS
    Starr, R
    Metcalf, D
    Nicholson, SE
    Farley, A
    Elefanty, AG
    Brysha, M
    Kile, BT
    Richardson, R
    Baca, M
    Zhang, JG
    Willson, TA
    Viney, EM
    Sprigg, NS
    Rakar, S
    Corbin, J
    Mifsud, S
    DiRago, L
    Cary, D
    Nicola, NA
    Hilton, DJ
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) : 588 - 592
  • [2] SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
    Alexander, WS
    Starr, R
    Fenner, JE
    Scott, GL
    Handman, E
    Sprigg, NS
    Corbin, JE
    Cornish, AL
    Darwiche, R
    Owczarek, CM
    Kay, TWH
    Nicola, NA
    Hertzog, PJ
    Metcalf, D
    Hilton, DJ
    [J]. CELL, 1999, 98 (05) : 597 - 608
  • [3] Effect of anti-interleukin 12 treatment on murine lyme borreliosis
    Anguita, J
    Persing, DH
    Rincon, M
    Barthold, SW
    Fikrig, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) : 1028 - 1034
  • [4] Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis
    Anguita, J
    Rincón, M
    Samanta, S
    Barthold, SW
    Flavell, RA
    Fikrig, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) : 1512 - 1515
  • [5] The IFN gamma receptor: A paradigm for cytokine receptor signaling
    Bach, EA
    Aguet, M
    Schreiber, RD
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 563 - &
  • [6] Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO
  • [7] 2-I
  • [8] Cellular responses to interferon-gamma
    Boehm, U
    Klamp, T
    Groot, M
    Howard, JC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 749 - 795
  • [9] Bradley LM, 1996, J IMMUNOL, V157, P1350
  • [10] Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches
    Constant, SL
    Bottomly, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 297 - 322